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ABSTRACT 
The impact of dietary habits on human health is well known and diet plays a significant role 
in chronic and age related diseases. This study had the following objectives: (1) to 
characterize the effects of different types of dietary carbohydrate on the expression of the 
digestive enzyme sucrose-isomaltase (SI) and of the glucose transporters SGLT1 and GLUT2 
(sodium dependent transporter and facilitated diffusion, respectively) in intestinal epithelial 
cells, and (2) describe the effects of the phytochemical agent RA on the modulation of these 
processes. 
Carbohydrate digestion and absorption by the intestine determine the rise in glucose levels of 
the blood after a meal and in diabetic patients these processes are increased which contributes 
to the hyperglycemia that characterizes the disease. Other dietary constituents, namely 
phytochemicals, may have a beneficial effect in this scenario by decreasing carbohydrate 
digestion and/or intestinal glucose uptake. This study shows that when carbohydrates are 
removed from the diet there is a marked decrease in SI, SGLT1 and GLUT2 not only at the 
apical membrane of enterocytes but also in enterocyte whole cell homogenates. Upon 
reintroduction of diets rich in carbohydrate (glucose or amylopectin) for 7 or 14 days, there is 
a marked increase in the enterocyte expression of the three proteins. The effects are more 
pronounced in the glucose diet which suggests a decisive role for luminal glucose on the 
adaptive response to increasing dietary carbohydrates. 
The phytochemical RA demonstrated to decrease the extent of the adaptive increase in the 
digestive enzyme as well as in the glucose transporters revealing its potential as a regulator of 
intestinal glucose absorption. 
This work is collaboration with Dr. Simon Lee of the University of Macau, China
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RESUMO 
Os efeitos da alimentação têm grande impacto sobre a saúde humana. Este trabalho tinha 
como objectivos (1) caracterizar os efeitos de diferentes fontes de hidratos de carbono na dieta 
de ratos sobre a expressão de enzimas digestivas e transportadores de glucose no epitélio 
intestinal (2) descrever os efeitos do agente fitoquímico RA na modulação destes processos. 
Como é sabido, a digestão e absorção de hidratos de carbono pelo intestino são processos que 
determinam a subida de glucose no plasma associado à dieta e podem, em doentes diabéticos 
por exemplo, estar aumentados o que agrava a hiperglicemia presente nestes doentes. Outros 
constituintes da dieta, nomeadamente agentes fitoquímicos, podem intervir beneficamente 
neste processo diminuindo a velocidade de digestão dos hidratos de carbono complexos e/ou 
eficiência do transporte de glucose para a circulação através de efeitos não só na actividade de 
enzimas digestivas mas também na expressão de transportadores de glucose na membrana 
apical de enterócitos. Assim, este estudo mostra que quando se retiram os hidratos de carbono 
da dieta de ratos previamente alimentados com uma dieta normal (contendo amido) os níveis 
da enzima sacarose-isomaltase e dos transportadores de glucose SGLT1 (sodium dependent 
glucose transporter 1) e do GLUT2 (difusão facilitada) baixam muito significativamente não 
só na membrana apical de enterócitos (BMM) como também nos extractos celulares totais de 
mucosa intestinal. Ao reintroduzir dietas isocalóricas ricas em hidratos de carbono de 
diferentes tipos –  glucose ou  amilopectina – por 7 ou 14 dias produzem adaptações ao nível 
da enzima e das proteínas transportadoras cuja expressão aumenta. Estes efeitos são mais 
pronunciados no caso da dieta com glucose (do que na dieta contendo amilopectina) o que 
indica um papel determinante da glucose lumenal livre na estimulaçãp destes mecanismos 
adaptativos. Os resultados confirmam ainda que a regulação do transporte da glucose e da 
sacarose-isomaltase parecem estar associados.  
O agente fitoquímico testado (RA) demonstrou ter potencial para conter estas respostas 
adaptativas ao aumento de glucose livre no lúmen do intestino o que revela que poderá ser útil 
no controle da glicemia. 
Este trabalho é o resultado de uma colaboração com o Doutor Simon Lee da Universidade de 
Macau, China.
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CHAPTER 1 
INTRODUCTION 
 Diabetes is increasing worldwide mainly due to non-healthy diets and lifestyles and 
dietary habits. According to WHO: 
 -More than 346 million people worldwide have diabetes. 
 -Type 2 accounts for around 90% of all diabetes worldwide. 
 -Diabetes is predicted to become the seventh leading cause of death in the world by 
the year 2030. 
 So, what is diabetes? It is an increase in glucose concentration in the blood (plasma 
glucose), as a result of either lacking insulin produced by the pancreatic beta cells (type 1) or 
the body’s ineffective response to insulin (type 2). While type 1 cannot be prevented, type 2 
can be. 
1.1. Glucose homeostasis 
 Glucose homeostasis is the result of the balanced action of two pancreatic hormones, 
insulin and glucagon, to maintain blood glucose concentration in the range of 3.9 to 5.6 mM. 
Intestinal glucose absorption, endogenous glucose production by the liver (gluconeogenesis) 
and glucose utilization by the tissues (glucose clearance) are responsible for glucose 
concentration in blood.  Although insulin, which removes glucose, and glucagon, which 
produces glucose, are consider as main factors for glucose concentration regulation, there are 
several other enzymes, substrates, and transporters that help to regulate the plasma glucose 
levels also (Aronoff et al., 2004). 
 Recent studies on diabetes focus on the small intestine where the absorption of glucose 
occurs. This means that we can control the plasma glucose concentration within appropriate 
limits for diabetic patients by reducing the glucose absorption ability of the intestine. There 
are several methods to do that such as inhibiting the glycosidase enzymes’ activity 
(carbohydrate digestion), or decreasing the expression of glucose transporters (SGLT1, 
GLUT2), which help to deliver glucose from food through the brush border membrane 
(BBM) of intestinal epithelial cells – enterocytes to the blood, and enhancing the incretion 
hormones secretion, which increase the insulin response to glucose and thereby helping to 
bring down plasma glucose after meal (Avezdo Mariza F. et al., 2008). 
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1.2. The small intestine 
 The small intestine is not only a digestive organ but also the place where amino acids, 
sugar, fatty acid particles, vitamins, electrolytes and water are absorbed. In human beings, the 
small intestine is about 2.8m long (Rhoades & Pflanzer, 2003) while it is 100cm long in rat 
(Miller, 1971). It includes three sections: duodenum (small portion), jejunum and ileum (both 
have similar length). 
 
Figure 1. Cross section and small structure of small intestine 
(http://www.daviddarling.info/encyclopedia/S/small_intestine.html) 
1.3. Carbohydrate digestion, absorption and glucose transporters (SGLT1, GLUT2) 
1.3.1. Carbohydrate digestion 
 Plants (rice, potato, wheat, etc…) are major supply sources of carbohydrates in the 
human diet. Their main composition is starch which can be digested to glucose by salivary 
and pancreatic amylases, as well as by disaccharides of the enterocyte brush border membrane 
(lactase, isomaltase, and maltase) (Rhoades & Pflanzer, 2003; Drozdowski & Thomson, 
2006b). 
 Sucrose-isomaltase (SI) is an apical membrane enzyme of small intestine, which is 
responsible for starch and sucrose digestion. SI, after being synthesized, is firstly attached to 
endoplasmic reticulum with N-glycosylation to become a high mannose precursor of 210kDa. 
Secondly, the precursor is terminal N- and O-glycosylated when moving to the Golgi 
apparatus. Finally, SI is translocated to the brush border membrane and is cut into sucrose and 
Chapter 1. Introduction 
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isomaltase units by pancreatic proteases in order to digest starch and sucrose to simple sugars 
(Kazuki Mochizuki et al., 2010). 
 
Figure 2. Sucrose-Isomaltase structure 
(http://es.123rf.com/photo_12771469_sacarasa-isomaltasa-enzima-estructura-es-la-enzima-
implicada-en-la-digestion-del-azucar.html) 
 Due to the importance of carbohydrate digestion and sugar absorption in small 
intestine, there are many studies on the effect of diets on the SI expression. According to 
Goda et al., 1994, a diet of high fat/carbohydrate ratio decreased sucrase, isomaltase and 
maltase activities, which also reduced the sucrase/isomaltase activity ratio (Goda et al., 1993). 
The cause of the decrease in SI activity ratio is explained by the change in glycosylation of SI, 
when it is synthesized from a single polypeptide, namely the reduction of unsialylated 
galactose from the glycosylated chain of the SI complex, (Kazuki et al., 2010).  
 Kazuhiro et al., 1999 demonstrated that fructose and sucrose diet (40% energy as 
fructose or sucrose) can enhance the transcription of SI and intestinal hexose transporters 
(SGLT1, GLUT5 and GLUT2) within short period of time (12h). On the other hand, the 
mRNA level of SI and GLUT5 couldn’t be enhanced by glucose or nonmetabolizable sugar 
(α-methyglucoside) within 12h. However, within a longer period of time (5 days), a high 
glucose diet could increase the SGLT1 and GLUT2 mRNA levels or both SI and SGLT1 
transcription also were increased with a high-starch diet for 7 days. Researchers therefore 
suggested two mechanisms to explain gene expression of SI and intestinal hexose transporters 
due to the carbohydrate diets: the first one is a fast gene transcription stimulated by fructose 
Chapter 1. Introduction 
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or sucrose (12h after meal) and the second one is generated by consumption of starch or 
glucose within long term period of time(≥5 days) (Kazuhiro et al., 1999). 
1.3.1 Carbohydrate absorption 
 After being digested, these monosaccharides (glucose, fructose and galactose) are 
absorbed through the enterocytes (George L.Kellet et al., 2008; Figure 3).   
 
Figure 3. Regulation of apical GLUT2 in enterocytes by calcium and taste receptors. GLUT, glucose 
transporter; PKC, protein kinase; PLC, phospholipase C; SGLT, sodium-dependent glucose transporter; 
Cav1.3, nonclassical neuroendocrine L-type voltage-dependent calcium channel (George L.Kellet et al., 
2008) 
 The tight junctions help to join enterocytes together in order to sustain the polarity of 
enterocyte with a brush border membrane (or apical membrane) and a basolateral membrane. 
In addition, these junctions limit molecules to move from the lumen to the blood via a 
paracellular route (Woudstra & Thomson, 2002). 
 Specific glucose transporters (SGLT1, GLUT2) help glucose and other 
monosaccharides diffuse into cells since these molecules are hydrophilic and cannot go 
through the lipid bilayer by themselves. Besides glucose, galactose and fructose after being 
absorbed mostly will be converted to glucose in enterocytes (liver will be responsible for the 
remaining) for later storage or metabolism. (Wright et al., 2003). 
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 In this study, we will focus mainly on two glucose transporters namely SGLT1 and 
GLUT2 so that firstly let’s have a look at them. 
 SGLT1, sodium-dependent glucose transporter, is the main transporter of glucose and 
galactose from the lumen across the enterocytes. 2 Na+ ions and 260 molecules of water are 
transported through the apical membrane along with the uptake of each glucose molecule 
(Wright et al., 2004). The majority of glucose after being absorbed into the enterocytes will be 
transported out of the cell by GLUT2, which is mainly located in the basolateral membrane of 
enterocytes. Besides the function as glucose transporters, GLUT2 can also transport galactose 
and fructose from the cytosol to the blood (Wright et al., 2003). In addition, GLUT5 
facilitates the fructose transportation across the brush border membrane. These above things 
are based on the classical model of secondary active intestine glucose absorption. However, 
there are new evidences that GLUT2 also can play a role in apical glucose absorption like 
SGLT1, which means that GLUT2 can be translocated to the apical membrane (Figure 3). 
1.3.2. Glucose transporters (SGLT1 & GLUT2) 
 SGLT1 (73 Da protein) is a member of the family of sodium dependent glucose 
transporters, which is found abundantly in the apical brush border membrane of jejunum (it’s 
also located in ileum and duodenum but at lower levels) (Wright et al., 2007; Yoshida et al., 
1995). Besides, SGLT1 can also be found in the cardiomyocytes (heart), luminal membrane 
of intracerebral capillary endothelial cells (brain) and the apical membrane of renal tubule 
cells (kidneys) (Bouche et al., 2004; Wright, 2001; Zhou et al., 2003; Elfeber et al., 2004). 
The secondary structure of SGLT1 is a 14 transmembrane α-helice with extracellular N and C 
terminus (Figure 4). It also has two phosphorylation site (between 6 & 7, 8 & 9 
transmembrane helices) and one glycosylation site (between 5 & 6 transmembrane helices) 
(Wright, 1998). SGLT1 can also be divided into two regions, according to their function. The 
first, called the N-terminal region (from helices 1-9), plays a role in locating of SGLT1 and 
binding Na+ whereas the second region, called the C-terminal region (from helices 10-14) is 
responsible for sugar binding and transport (Wright et al., 2004; Panayotova-Heiermann et al., 
1997; Suzuki et al., 2001). 
 Glucose and galactose can be transported into the cell against their concentration 
gradients by SGLT1 due to the electrochemical gradient of Na+ (Bouche et al., 2004; Wright 
et al., 2007). In addition, SGLT1 is also considered as a water and urea channel (Wright et al., 
2002). 
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Figure 4. The secondary structure of SGLT1 
(http://physiologyonline.physiology.org/content/19/6/370/F1.expansion.html). 
 Another important glucose transporter is GLUT2 (52-60 kDa in molecular weight), 
which is found mostly in the basolateral membrane of  jejunum of the small intestine, liver, 
kidney and pancreatic β-cells (Hogan et al., 1991; Bouche et al., 2004). According to Figure 
5, the secondary structure of GLUT2 consists of 12 transmembrane helices with intrancellular 
N and C terminus and a larger intracellular loop, which connects 6th & 7th helice (Bouche et 
al., 2004) 
 
Figure 5. Secondary structure of GLUT2 (Kazuaki et al., 2005) 
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  According to the classical model of glucose absorption, GLUT2 is considered to 
present only in the basolateral membrane. However, some recent studies showed that GLUT2 
can be translocated to the brush border membrane in normal rats with high sugar meal.  
 GLUT2 can be a permanent resident of brush border membrane due to fructose and fat 
diet in type 2 diabetic experimental rats, which will enhance the absorption of sugar. (George 
L.Kellett et al., 2008). According to Oliver J.Mace et al., 2007, GLUT2 translocated rapidly 
to the brush border membrane due to high concentration of glucose in small intestine (30-200 
mM) but low glucose concentration (≤20 mM) did not produce any effects in GLUT2 
translocation. However, at low glucose concentration with the present of artificial sweeteners 
(1-2 mM), GLUT2 can also be trafficked to apical membrane. Sucralose, acesulfame 
potassium and saccharin (3 common artificial sweeteners) increase the level of apical GLUT2 
(Oliver J.Mace et al., 2007). 
1.4. Sources of bioactive compounds from medicinal plants 
 Using traditional medicinal plants as an antidiabetic therapy has been recorded long 
before the use of insulin in 1922 (Day, 1998). However, until now, scientists can’t find any 
natural source of insulin from plant to apply for T1DM patients. On the other hand, for 
T2DM, since insulin treatment is not the ideal approach, alternative medicines from herbs 
might be considered as good complementary treatment (Avezdo F. et al). For example, 
ginseng (Panax spp.), ivy gourd (Coccinia indicia), garlic and onion (Allium sativum and 
Allium cepa), holy basil (Ocimun sanctum), milk thistle (Silibum marianum), gurmar 
(Gymnena sylvestre), bitter melon (Momordica charantia),  Aloe vera and  Ginkgo biloba are 
considered as promising antidiabetic plants (Vuksan & Sievenpiper, 2005). Three 
mechanisms of these antidiabetic plants are the increase of glucose disposal-uptake by muscle 
and adipose tissues (e.g. ginseng, fenugreek, fig leaf, ivy gourd, bitter melon), the delay of 
glucose absorption in the gut (e.g. Aloe vera, ginseng, prickly pear cactus, fenugreek), and the 
glucose stimulated insulin secretion (e.g. ginseng, garlic, holy basil, bitter melon, gurmar) 
(Vuksan & Sievenpiper, 2005). 
Since the hyperglycaemia results in production of more oxidative damage in cells, the 
antioxidant compounds from herbs (phenolic compounds, alkaloids, flavonoids and 
glycosides) may support their antidiabetic effects (Roberson & Harmon, 2006). Tanaka et al. 
also demonstrated in their studies with diabetic animals that antioxidants decrease diabetes 
progression. 
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1.5. Rosmarinic acid 
 Rosmarinic acid (RA), which is widely found in species of the Boraginaceae and the 
subfamily Nepetoideae of Lamiaceae, is an interesting biological compound. It can function 
as an antioxidant, ativiral, antibacterial and anti-inflammatory. RA’s chemical structure is an 
ester of caffeic acid and 3,4-dihydroxyphenyllactic acid (Figure 7) 
 
Figure 6. Structure of rosmarinic acid (Toth J. et al., 2003) 
Rosmarinic acid has also been found from other plant families (Table 2) 
Table 1. RA’s occurrence in the plant kingdom (Maike Petersen et al., 2002) 
 
 Previous studies showed that RA doesn’t exist long in the blood circulation (t=81 
minute) and its toxicity is low (LD50 = 561mg/kg in mice) (Parnham and Kesselring, 1985). 
Furthermore, RA is also applied in cancer treatment and cosmetic industry due to its anti-
oxidant activity (D’Amelio, 1999). In addition, RA, which corresponds to 72% of the total 
phenolics in herb S.fruticosa, could play an important role in controlling the hypeglycaemic 
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since it decreased SGLT1 levels at the BBM as it decreased the level of heat shock protein-
Hsp70, which has been reported to enhance the translocation of SGLT1 to the BBM (Mariza 
F.Azevedo et al., 2010). 
In order to clarify the interrelation of SI and SGLT1 regulated in enterocytes by dietary 
carbohydrate, an experiment was performed with rats fed with glucose or amyplopectin. 
Glucose is readily absorbed in the intestine through BBM glucose transporters such as SGLT1 
or GLUT2, and amylopectin needs to be digested by BBM enzymes such as SI in order for 
glucose to be released and absorbed. With the use of two diets above (glucose and 
amylopectin), we expect to see how independent is the upregulation of glucose transporters 
and SI in BBM of rats at 4 and 14 days after introduction of these diets to animals which were 
previously fed for 1 week on CH free diet (that helped to reduce the expression of SGLT1 and 
SI in BBM). 
The effects of RA, previously demonstrated to reduce BBM SGLT1 expression in starch fed 
animals, is also tested in this study. 
Total gene expression (SGLT1, GLUT2 and SI) in whole cell homogenates and the 
translocation to the BBM will be discussed with the parameters varying with diet, time and 
RA treatment. 
 10 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1. Chemicals and solutions 
2.1.1 Brush Border Membranes (BBM) isolation solutions 
Buffer 1: 1 l 
100 mM manitol 18.22 g 
2 mM Hepes/Tris, pH 7.1 0.477g Hepes (MHepes=238.5 g/mol) 
(pH with 2M Tris) 
Buffer 2: 500 ml 
100 mM manitol 9.11 g 
2 mM Hepes/Tris, pH 7.5 0.238 g Hepes (MHepes=238.5 g/mol) 
0.1 mM MgSO4 0.5 ml stock MgSO4 100 mM 
(pH with 2M Tris) 
Buffer 3: 100 ml 
300 mM manitol 5.466 g 
20 mM Hepes/Tris, pH 7.5 0.477g Hepes (MHepes=238.5 g/mol) 
0.1 mM MgSO4 0.1 ml stock MgSO4 100 mM 
0.02% NaN3 0.2 ml stock 10% (w/v) 
(pH with 2M Tris) 
2.1.2. Western blot solution 
2.1.2.1. Gel solutions 
Resolving gel (*) 
 
 
% Acrylamide Range of separation (KDa) 
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15ml (2 gels) 5% 8% 12% 10% 15% 
H2O UP 8,75ml 7.25ml 5,25ml 6,145ml 3,65ml 
4x Tris-HCl/SDS, pH= 
8,8 
3,75ml 3.75ml 3.75ml 3,750ml 3.75ml 
30% Acryl: 0,8%Bis  2,53ml 4.05ml 6ml 5ml 7,5ml 
10% APS (100mg/ml) 75µl 75µl 75µl 75µl 75µl 
TEMED 30µl 30µl 30µl 30µl 30µl 
 
7,5ml (1 gel)  5% 8% 12% 10% 15% 
H2O UP 4,375ml 3,625ml   2,625ml 3,073ml 1,825ml 
4x Tris-HCl/SDS, pH= 
8,8 
1,875ml 1,875ml   1,875ml 1,875ml 1,875ml 
30% Acryl: 0,8%Bis  1,265ml 2,025ml 3ml 2,500ml 3,75ml 
10% APS (100mg/ml) 37,5µl 37,5µl 37,5µl 37,5µl 37,5µl 
TEMED 15µl 15µl 15µl 15µl 15µl 
(*): Resolving gel used in this experiment is an 8% gel. 
15 12-43 
10 16-68 
7.5 36-94 
5 57-212 
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Stacking gel 
 30% Acrylamide/0,8% Bisacrylamide  
(USING MASK)                                                            
                     50ml               100ml           200ml 
            Acrylamide       (478)                  14.6g               29.2g             58.4g 
            Bisacrylamide    (137)                 0.4g                  0.8g              1.6g 
For 100ml: Add 29.2g de Acrylamide, 0.8g de N,N’-methylenebisacrylamide and H2O UP to 
100ml. Filtrate a solution (filter 0.45µm) and keep a 4ºC, in dark. 
 4X Tris-HCl/SDS, pH 6.8   (0.5M Tris-HCl containing 0.4% SDS) 
                 40ml         50ml           100ml 
             Tris base   (128)          2,42g        3.025g         6.05g           (pH=6.8 with HCl 6N) 
             SDS    (67)                  0,16g            0.2g           0.4g 
For 100ml: Dissolve 6.05g Tris base in 40ml H2O UP and adjust pH to 6.8 with 6N HCl, add 
H2O UP to 100ml. Filtrate the solution (filter 0.45µm and syringe 20ml) and add 0.4g SDS. 
Keep at 4ºC. 
 
 
3,9% Acrylamide 1 Gel 2 Gels 
H2O UP 3,05ml   6,1ml   
4x Tris-HCl/SDS, pH= 6,8   1,25ml     2,5ml   
30% Acryl: 0,8%Bis 650µl 1,3ml 
Bromophenol Blue 25µl (0.5%)  50µl (0.5%) ; 100µl (0,05%) 
10% APS (100mg/ml)  25µl  50µl 
TEMED 20µl 40µl 
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 4x Tris-HCl/SDS, pH 8.8    (1.5M Tris-HCl containing 0.4% SDS) 
                                              150ml         100ml      500ml 
        Tris base (128)           27.23g        18.15g        91g          (pH=8.8 with HCl 6N) 
       SDS     (67)                 0.6g             0.4g           2g 
For 100ml: Dissolve 18,15g Tris base in 60ml H2O UP and adjust pH to 8.8 with 6N HCl. 
Filtrate the solution (filter 0.45µm e syringe 20ml) + 4ml SDS10X, add H2O UP until 100ml. 
Keep at 4ºC. 
 10% APS (Ammonium Persulfate) 
0,02g (20mg) APS (powder) + 200µl H2O UP      
 Bromophenol Blue (0.05% Bromophenol Blue in Tris-HCl 6.8) 
                      5mg Bromophenol Blue + 10ml Tris-HCl 6.8 (adjust pH=6.8) 
2.1.2.2. Buffers 
Towbin buffer 5X 
  5X 
 25mM Tris base 15.1g 
 192mM Glycine 72g 
 H2O UP 1L 
• Dissolve Tris base and Glycine in around 800ml H2O UP 
• Add H2O UP until 1L 
• Keep in 40C champer 
Running buffer 
  400ml (for 2 gels) 
 Towbin buffer 5X 80ml 
 0.1% SDS 4ml (from the SDS 10% solution) 
 H2O UP 316ml 
• Stir the solution  
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• Keep at 40C 
Transfer buffer 5X (Semi-dry blotting) 
  1000ml 
 48mM Tris base 29.1g 
 39mM Glycine 14.65g 
 0.0375% SDS 1.875g 
 H2O UP 1L 
Transfer buffer 
 150ml (1 gel) 300ml (2 gels) 
Transfer buffer 5X 30ml 60ml 
Absolute Metanol 7.5ml 15ml 
H2O UP 112.5ml 225ml 
TPBS (0.05% Tween20, PBS pH=7.4) 
PBS 10X 100ml 
H2O UP 900ml 
Tween20 500 µl 
Stripping buffer 
  250ml 
 62.5mM Tris-base 1.893g 
 2% SDS 5g 
 100mM 2-Mercaptoetanol 1.748ml 
• Dissolve Tris base in 230ml H2O UP 
• Adjust pH to 6.7 with HCl concentrated 
• Add SDS and dissolve by gently stirring (to avoid making bubbles) 
• Add H2O UP until 250ml and put all the solution in a bottle 
• Add 2-Mercaptoetanol in the hood 
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• Keep the solution at room temperature in the hood 
SDS Sample Buffer 2X (Laemmli sample buffer) 
            50ml                  
 -0.125M Tris-HCl, pH 6.8 (stock 0.5M) 12.5ml                 
 -20% Glycerol 12.6g (10ml)       
 -4% SDS (stock 10%) 20ml                      
 -0,01% Bromophenol Blue (stock 0,5%) 1,0ml 
        -H2O UP 45ml 
• Dissolve all the components in the solution 
• Filtrate the solution with 0.22µm filter 
• Make 900µl aliquots 
• Keep at -200C 
Before using, add 100µl DTT 1M in each 900µl aliquot. Reuse the solution remaining (keep 
at -200C) 
DTT 1M: 1ml H2O + 154.3mg DTT (40C, MW=154.3mg/ml) 
2.1.2.3. Blocking solution 
  1 Membrane 2 Membranes 
 TPBS 25ml 50ml 
 5% Skim milk 1.25 2.5g 
2.1.2.4. Antibody solutions 
First Antibody 
  10ml 
1% BSA 100mg 
0.05% Sodium Azide (NaN3) 50µl (Stock 10%) 
TPBS 10ml 
First antibody * 
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* Volume varies depends on the 1st antibody prepared (see the manufacturer’s 
recommendation) 
Sodium Azide 10%: 1g azide + 10ml H2O UP 
Secondary antibody (to be freshly made) 
  10ml 
5% Skim milk 0.5g 
TPBS 10ml 
Secondary antibody 3µl* 
*Volume can varies depends on the type of antibody used 
2.1.2.5. Gel staining/distaining solutions 
Gel staining solution 
 1000ml 
 0.1% Coomasive Blue 1ml 
 5% Ethanol 50ml 
 7% Methanol 70ml 
 H2O UP 879ml 
-Immerse the gel in staining solution 
-Incubate at room temperature in 1h 
-The solution can be reused 
Gel distaining solution 
  1000ml 
 25% Methanol 70ml 
 5% Acid Acetic 50ml 
 H2O UP 880ml 
-Distain the gel during 30 minutes in the hood 
-Change the distaining solution and leave it with agitation 
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 Ethanol 95%        
95ml ethanol Pure + 5ml H2O UP 
76ml ethanol Pure + 5ml H2O UP 
 SDS 10X       10g SDS (67)  + 90ml H2O UP 
(Add H2O UP to 100ml) 
 Membranas PVDF:      5,9 X 8,8 cm 
 Papel Watman:    6,3 X 9,1 cm 
2.2. Animal 
100 small intestine samples collected from 10 groups of rat (10 samples/group). 
Experiment with 100 male rats with ~150g 
Feeding regimes: 
HCD – normal rat chow 
LCD – high protein, low carbohydrate diet (7days) 
HCD1 – high glucose diet (4 days and 15 days) 
HCD2 – high amylopectin diet (4 days and 15 days) 
(The different diets are isocaloric) 
W – Tap water drinking 
RA – rosmarinic acid in tap water drinking (~600ug/ml) 
Groups of rats: 
Group 1 (G1): 11 days on HCD/W diet 
Group 2 (G2): ~7 days on HCD/W + 7 days on LCD/W 
Group 3 (G3): 7d on HCD/W + 7d on LCD/W + 4 days on HCD1/W 
Group 4 (G4): 7d on HCD/W + 7d on LCD/W + 4 days on HCD1/RA 
Group 5 (G5): 7d on HCD/W + 7d on LCD/W + 4 days on HCD2/W 
Group 6 (G6): 7d on HCD/W + 7d on LCD/W + 4 days on HCD2/RA 
Group 7 (G7): 7d on HCD/W + 7d on LCD/W + 15 days on HCD1/W 
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Group 8 (G8): 7d on HCD/W + 7d on LCD/W + 15 days on HCD1/RA 
Group 9 (G9): 7d on HCD/W + 7d on LCD/W + 15 days on HCD2/W 
Group 10 (G10): 7d on HCD/W + 7d on LCD/W + 15 days on HCD2/RA 
2.3. Methods 
2.3.1. Preparation of brush-border membrane vesicles (BBMV) 
This method can be used with fresh and frozen tissues. 
All steps should be done at 4ºC  4ºC Room.   
Procedure Notes 
 
1. Place all the equipment in the 4ºC room some time in 
advance to adapt to the correct temperature. 
 
2. Place 50 ml of buffer 1 in the homogenizer container. 
Take the sample (~2g) from the criotube (still frozen) and 
place in the 50 ml of buffer (wait about 2-3 min to defrost). 
 
3. Homogenize (in the Waring Blender), at VLO, for 30 sec. 
Wait about 1 – 2 min to slow down again the temperature of 
the system. 
 
4. Homogenize again at VLO for 30 sec.  
 
5. Filter the homogenate through a nylon filter (yellow) to 
two 50 ml-tube (25 ml for each).  
        Take about 1 ml of crude homogenate (Hi) 
 
 
 
 
 
 
 
 
 Nylon yellow filters 
(0.45 µm) 
 
 
 Hi = total volume of 
50 ml 
 
 
 
 Total volume: 2 x 50 
ml = 100 ml diluted Hi 
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6. Add buffer 1 to each tube until 50 ml. 
 
 
 
7. To each 50 ml-tube, add 200 µl of MgCl2 (2.5 M) to 
obtain a final concentration of 10 mM MgCl2. Stir on ice 
during 20 min. (3 in 3 minutes) 
 
     Meanwhile switch on the 50 ml-tube centrifuge for 
cooling at 4ºC. 
 
 
 
8. Centrifuge all tubes at 3,000 x g (Eppendorf Centrifuge 
5804 R) for 10 min.  
    Meanwhile switch on the Avanti centrifuge for cooling 
at 4ºC. 
 
 
 
 
 
9. Reject the pellet and join supernatant from the same 
sample in a 100 ml goblet. Divide sample for 3 tubes of 
Avanti centrifuge and centrifuge supernatant at 30,000 x g 
(15.749 rpm, JA25-50 rotor, Beckman Avanti J-25I) for 30 
min. 
 
 
 
 
 
(the divalent cations will 
crosslink with all non-
BBM membranes to 
induce precipitation)  
(At this point all 
connective tissue, intact-
cells, debris, nuclei, 
mitochondria, basolateral 
and intracellular 
membranes will collect in 
the pellet leaving BBM in 
the supernatant) 
 
Be careful to correctly 
identify the goblet with 
the correct sample, and 
place on ice. Cover goblet 
with aluminium foil. 
 
 
CALIBRATE VERY 
WELL THE TUBES in 
a balance. 
(centrifugation is to pellet 
the  
Brush-border membranes. 
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10.Resuspend pellet of each tube with 10ml of buffer 2 (10 
strokes – with a 5 ml syringe + a yellow tip). Join all the 
BBM from the same sample in one tube. 
 
11.Centrifuge tubes at 30,000 x g (15.749 rpm, JA25-50 
rotor, Beckman Avanti J-25I) for 45 min. 
 
12.Resuspend pellet (BBM) in 1-2 ml of buffer 3 (first with 
a P1000 pipette and then passing through a 27 gauge needle 
at least six times). 
       Use a 1 ml or 2 ml syringe. 
 
13. Make BBM granules in liquid nitrogen and keep it at      
-80ºC (for Western blot), or in liquid nitrogen (if it is to use 
in transport studies). 
 
The second supernatant is 
discarded -contains only 
soluble cytosolic 
proteins). 
 Total volume: 3 x 11 
ml = ~33 ml of diluted 
BBM 
 
 
CALIBRATE VERY 
WELL THE TUBES in 
a balance. 
 
(to “wash” BBM - to 
remove the last of the 
MgCl2; BBM are 
precipitated again) 
 
 
(This procedure does not 
damage the membranes 
and helps to form the 
vesicles) 
• Protein concentration 
should be higher than ~5 
– 7 mg/ml.  
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MATERIAL    (for isolation of 2 samples - 2 rats) 
  2 boxes with ice 
  Waring Blender + Container 37-110 mL 
  1 50 mL graduated cylinder 
  1 forceps 
  4 50 mL-tube/rat 
  2 nylon filters 
  P200 + tips 
  1 plastic Goblet for residues 
  2 glass Goblets >100mL + Aluminium foil 
  6 Avanti centrifuge tubes 
  P1000 + tips (for calibration of tubes in the balance) 
  2 5mL-syringe + 2 yellow tips 
  2 2mL-tubes  
  Container for liquid N2 to make BBM and Hi granules 
  Plastic spoon to recover BBM and Hi granules made in liquid N2 
  Criotubes to keep samples at -80ºC (Hi e BBMV) 
  Time counter 
  Liquid N2 + appropriate container 
  Cleaning paper 
  Goblet to reject supernatant from centrifugation of BBM (to avoid pellet detachment when 
coming to the laboratory). 
2.3.2. Determination of Protein (BRADFORD Method) 
Sample dilution: 
Hi – dilute 1:2 or no dilution (20µl sample + 20µl buffer1 from protocol of BBMV isolation). 
BBMV – dilute 1:10  (4µl sample  + 36µl  buffer3 from protocol of BBMV isolation) 
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Make 2 Standard curves: 
+ BSA 5mg/mL in buffer 1 to Hi 
+ BSA 5mg/mL in buffer 3 to BBMV 
Standards: 
5mg/mL 3mg/mL 2mg/mL  1mg/mL 0.5mg/mL 0.25mg/mL 
Pipette to a 96-well plate in the following order: 
Hi 
-First: 
5µl blank (buffer 1) 
5µl standard (total of 6 standards in 6 wells)   
5µl sample 
-Second: 
250µl Bradford Reagent 
 Incubate 5-10 min,  room temp. 
BBM 
-First
 
5µl blank (buffer 3) 
5µl standard (total of 6 standards in 6 wells)   
5µl sample 
-Second: 
250µl Bradford Reagent 
 Incubate 5-10 min,  room temp. 
2.3.2. Western blot 
2.3.2.1. Preparing the gel 
-Resuspend all the necessary components (APS and TEMED should be added at the end) and 
pour quickly with p1000 into the two glasses. 
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-Immediately adding 95% ethanol on the top of the resolving gel and let it polymerize in 40 
minutes. (Ethanol helps the gel avoid being contacted with O2, which inhibits the 
polymerization). 
-While waiting for the solidification of the gel, we can make the stacking gel (without adding 
APS and TEMED) and prepare the running buffer. 
-After the first gel has solidified, pour out the ethanol and wash 2 times with H2O UP, then dry 
with filter paper without touching the gel. 
-Pour the stacking gel into the remaining empty space of the glasses, put the combs and wait 
for 15-20 minutes for the stacking gel gets solidified. 
 
Figure 7. Gel after being prepared. 
2.3.2.2. Electrophoresis 
-Put the glasses with the gel into the electrophoresis system with the combs facing inward. 
-Pour the running buffer into the mini tank, fill the space between the gels and remove the 
bubbles. 
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Figure 8. Gels and running buffer inside an electrophoresis system. 
-Cover and leave the tank with gel + buffer in 40C overnight or continue. 
-Carefully remove the combs while the system is immersed in the running buffer and use p100 
to wash the wells with running buffer. 
-Prepare to run the samples treated with SDS in order to have the protein concentration around 
20µg/µl. 
-Load the wells (15 wells/gel) with the same volume: 
 +1st well: 5-10µl Molecular Marker All Blue Bio-Rad + 15-20µl SDS buffer 
 + 13 next wells: 20-30µl samples (in order to have 20µg protein/well) 
 + last well: SDS buffer 
-Cover the tank and connect to the power: 
 +Run at 100V in 15 minutes to let the samples concentrate at the beginning of the 
separation gel. 
 +After that, run at 150V in 1 hour for separating the samples in the resolving gel. 
2.3.2.3. Transfer – Semi dry blotting 
-Prepare the transfer buffer: 300ml for 2 gels/ 150ml for 1 gel. (1) 
-Incubate 3MM paper (2 papers/gel) in transfer buffer for 15 minutes with agitation. (2) 
-Incubate the PVDF membrane, which was marked, hydrated 1 min in methanol, and washed 
3X in water, in transfer buffer for 15 minutes with agitation. (3) 
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-After the electrophoresis running finished, remove the gel support and the stacking gel, make a 
mark on the opposite side to the marker on the resolving gel by cutting a square or a triangle; 
then place it in transfer buffer in 20 minutes with agitation. 
*Note: (1), (2) and (3) should be prepared during 1 hour electrophoresis running. 
-Construct the sandwich in Trans-SD Blotting:  
 Cathode (top plate) 
  -Paper Watman 3MM (4) 
  -Gel (3) 
  -PVDF Membrane (2) 
  -Paper Watman 3MM (1) 
 Anode (low plate) 
Roll with the cylinder to remove bubbles. Dry the excess of liquid around the sandwich. The 
proteins with negatively charged due to the buffer will be transferred from the gel to the 
membrane in a cathode (-) to anode (+) direction. 
-Place the lid, connect to the electric power and turning to 15V for 40 minutes (for gels 1.5mm) 
-After 40 minutes transferring, disconnect the equipment: 
 +Place the membranes in TPBS for 10 minutes, agitating 2X 
 +Place the gel in Coomassie for 20 minutes, then water and let it be agitated as long as 
you wish. 
2.3.2.4. Marking with antibody – Immunodetection 
-Remove the TPBS and incubate the membranes with blocking buffer in 1-2 hours at room 
temperature with agitation, or leave overnight at 40C. This blocking step helps unoccupied sites 
of the membrane be saturated and prevent the non-specific bindings of the antibodies. 
-Remove the blocking solution and wash the membranes 3X with TPBS for 5-10-15 minutes. 
-Incubate the membranes with primary antibody (*) at 40C overnight in the roller falcon. 
-Take the membranes out of the primary antibody falcon (reusable) and wash 3X in TBPS for 
5-10-15 minutes. 
-Incubate the membranes with conjugate 2nd antibody (**) for 1 hour at room temperature. (2nd 
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antibody can be anti-rabbit, anti-mouse or anti-goat…depends on the primary antibody) 
Note: 
(*): primary antibodies used are SGLT1 (ab 14686, Abcam), GLUT2 (Anti-Glut2 Millipore, 
07-1402) and SI (Sucrase isomaltase L-20, sc-27608, Santa Cruz). 
(**): secondary antibodies used are Anti-rabbit IgG, HRP-linked Antibody, Cell Signaling, 
7074 and Donkey anti-goat IgG-HRP: sc-2033, Santacruz.
 
2.3.2.5. Detection 
-Turn on the PC and activate Program Quantaty One 4.6>File>ChemidocXRS (*) 
-Prepare a solution Amersham ECL TM Kit or Millipore Western Blotting Detection Kit 
1A:1B (40C) – Adding 400µl solution A + 400µl solution B (for one membrane) and mix well. 
-Remove the membrane from the TPBS buffer and put it on a plastic; pour the solution 
prepared before onto the membrane and leave in 1 minute. 
-Dry the membrane by dripping it on the absorbent paper then put it in a plastic membrane. 
Reveal the membrane inside the ChemidocXRS system. 
-In the apparatus: 
 +UV filter (the tab)>button EpiWhite : for marker photo 
 +Chemi filter>disconnect button EpiWhite: for bands photo 
-In the PC: 
 +(*)>select>cristovao membrane>zoom>freeze>auto expose: for marker photo 
 +select>chemidoc HS>Iris open>choose exposure time (first: 20 second)>manual expose 
-Photo saves: File>Save as and File>Export JPEG>Export 
-Quantify bands: Open file you want to quantify>Volume button Quick Guide>Button 
4th>circling bands>button 9th>vol Adj>done. 
2.3.3. Experimental design 
 The animals were fed a regular rat chow for 1 week before being fast sampled and 
introduced of the low carbohydrate diet - LCH diet (see composition in Table 3). A week later, 
the animal were sampled again and assigned (10 per group) to 4 different treatments: 
 +High glucose diet (HGD)-water (W). 
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 +High glucose diet (HGD)-rosmarinic acid (RA). 
 +High amylopectin diet (HAD)-water (W). 
 +High amylopectin diet (HAD)-rosmarinic acid (RA). 
Table 2. Diets’ composition 
Diets 
Composition 
LCH HGD HAD 
Casein, % 
Amylopectin corn starch, % 
Glucose, % 
Cellulose powder (68% CF), % 
L-Cysteine, % 
Minerals & trace elements, % 
Vitamin premix, % 
Choline Chloride, % 
Soybean oil, % 
53,300 
28,000 
-------- 
6,000 
0.500 
6,000 
1,000 
0,200 
5,000 
20,500 
-------- 
61,000 
6,000 
0,300 
6,000 
1,000 
0,200 
5,000 
20,500 
61,000 
-------- 
5,000 
0,300 
6,000 
1,000 
0,200 
6,000 
Crude protein, % 
Crude fat, % 
Crude firbe, % 
Crude ash, % 
Starch, % 
Sugar, % (1) 
47,3 
5,2 
4,1 
5,7 
28,0 
0,8 
18,3 
5,1 
4,1 
5,3 
------- 
61,6 
18,3 
5,1 
4,1 
5,3 
60,2 
0,8 
Energy (Atwater), MJ/kg 
  kJ% Protein 
  kJ% carbohydrate 
15,3 
52 
35 
15,8 
19 
69 
15,8 
20 
68 
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  kJ% Fat 13 12 12 
Fatty acid, % of diets 
  C14:0 
  C16:0 
  C18:0 
  C20:0 
  C16:1 
  C18:1 
  C18:2 n6 
  C18:3 n3 
 
0,05 
0,60 
0,26 
0,03 
0,03 
1,37 
2,66 
0,33 
 
0,03 
0,55 
0,24 
0,03 
0,03 
1,33 
2,65 
0,33 
 
0,03 
0,55 
0,24 
0,03 
0,03 
1,33 
2,65 
0,33 
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CHAPTER 3 
RESULTS AND DISCUSSION 
In this study, rats fed a normal diet for 7 days (NFD), were fed a low carbohydrate diet (LCH) 
for another 7 days in order to decrease enterocyte levels of sucrose-isomaltase (SI), sodium 
dependent glucose transporter 1 (SGLT1) and glucose transporter 2 (GLUT2), proteins 
involved in carbohydrate digestion and glucose absorption. After this, the animals were 
divided in groups and the diets changed to high glucose (HGD) or high amylopectin (HAD) 
with or without rosmarinic acid in the drinking water. Small intestinal mucosal samples were 
taken at 4 and 14 days.  
After the 7 days on the low carbohydrate diet (LCD) decreases in protein levels of SI, SGLT1 
and GLUT2 were observed. These results are in agreement with previous data reported by us 
and others (Azevedo et al., 2011). 
Generally, upon the reintroduction of CH (as glucose or as amylopectin), we observed an 
increase in expression of SI, SGLT1 and GLUT2 in whole cell homogenates. However, for 
these proteins to play a role in carbohydrate digestion and absorption from the intestinal 
lumen, they need to be translocated to the brush border membrane (BBM) of enterocytes. 
Therefore, the data is presented as BBM levels and whole cell levels of each of the proteins. 
We interpreted increases in whole cell homogenate levels of the above proteins as the result of 
increase gene expression and the increase in BBM expression levels as a consequence of 
protein translocation from the cell’s cytosol to the apical membrane. The effects of diet (type 
of carbohydrate) will be discussed first and the modulation by RA will be presented last. 
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Effect of diets & Rosmarinic Acid (RA) on SI’s expression and translocation 
 
Figure 9. Effects of diets and RA on SI level in jejunal BBM (♦) 
(♦) Legend: 
d – Days 
RA – Rosmarinic Acid 
NCH – Normal Carbohydrate Diet  
LCH – Low Carbohydrate Diet 
HGD – High Glucose Diet 
HAD – High Amylopectin Diet 
Statistics (unpaired t-tests): 
$ - P<0.05; $$ - P<0.01; $$$ - P<0.001 when compared with each other 
NS – Not significant (P>0.05) when compared with each other  
* - P<0.05; ** - P<0.01; *** - P<0.001 when compared with LCD group  
# - P<0.05; ## - P<0.01; ### - P<0.001 when compared with the respective treatment group 
for 4 days. 
a - P<0.05; aa - P<0.01; aaa - P<0.001 when compared with NCD group. 
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Relative the LCD, when either glucose or amylopectin were introduced in the diet there is an 
increase in SI at the BBM which is more significant in the glucose diet than in amylopectin 
diet (Figure 9). These results are interesting since amylopectin and not glucose is the substrate 
to this enzyme.  
In the whole cell homogenates of HAD animals there is no increase in SI expression relative 
to the LCD animals at 4 days with a very small increase present at 14 days  (Figure 10). Total 
SI expression levels in the glucose diet were similar to those in the NCD which indicates that 
in this group less than 4 days were needed to recover normal SI expression. From our data, it 
seems that free luminal glucose plays an important role in the induction of both translocation 
(Figure 9) and expression of SI (Figure 10). 
 
Figure 10. Effect of diets & Rosmarinic Acid (RA) on SI expression 
in jejunal whole cell homogenates (♦) 
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Effect of diets & Rosmarinic Acid (RA) on SGLT1 expression and translocation
  
Figure 11. Effect of diets & Rosmarinic Acid (RA) on SGLT1 expression 
in jejunal whole cell homogenates (♦) 
 
Figure 12. Effects of diets and RA on SGLT1 level in jejunal BBM (♦) 
 SGLT1 has been shown to increase in parallel with SI in response to increased CH in 
the diet. In whole cell homogenate, SGLT1 expression increased after the LCD with glucose 
but not amyplopectin. (Figure 11). However, BBM SGLT1 increased in both glucose and 
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amylopectin diet (Figure 12). This seems to indicate that the presence of glucose, even in low 
amounts (HAD) is responsible for the translocation of SGLT1 to the BBM, a process that 
does not require a de novo synthesis of SGLT1. When luminal glucose is high (HGD), in 
addition to a translocation effect, glucose seems to also have an effect on increasing SGLT1 
gene expression. 
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Effect of diets & Rosmarinic Acid (RA) on GLUT2 expression and translocation  
  
Figure 13. Effect of diets & Rosmarinic Acid (RA) on GLUT2 expression 
in jejunal whole cell homogenates (♦) 
 
Figure 14. Effects of diets and RA on GLUT2 level in jejunal BBM (♦) 
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With regards to GLUT2, there seems not to be a consistent increase in gene expression after 
reintroduction of CH (Figure 13). However, there was a very significant effect of luminal 
glucose on GLUT2 translocation to the BBM, where it is usually present in very low amounts 
since it is a basolateral protein (Figure 14). This effect of glucose on GLUT2 translocation to 
the BBM has also been reported by Kellet et al., 2008.  
Regarding RA’s effect in whole cell homogenate levels of SI and SGLT1, it decreased both 
SGLT1 and SI expression in HGD (but not HAD). When analyzing BBM levels of the 
protein, we found a significant decrease of SI in HAD animals and 14 day glucose fed animals 
(Figure 10). This effect seems to be similar to the one on BBM SGLT1 of HGD animals. 
However, in HAD animals, RA only decreased BBM SGLT1 level at 4 day (not 14 days like 
in SI’s case). RA had also already been shown to decrease BBM SGLT1 level in rat 
enterocytes (Azevedo et al., 2011). In that previous report, where a significant effect of RA 
was demonstrated already at 4 days, the animals had been fed a starch diet (which is 
composed by amylose and amylopectin), not a glucose diet. The effect of RA on starch and 
amylopectin fed animals seem to suggest that RA inhibits the digestive process to which SI 
contributes which is in agreement with SI data. In fact, RA significantly decreased SI BBM 
levels in HAD group (Figure 9). 
 In general, we can see that RA effects on BBM SGLT1 and SI levels follow the same 
pattern and could be explained by an inhibition of both SI and SGLT1 translocation. 
 In glucose fed animals, at 4 days, RA did not decrease either SGLT1 or SI in the 
BBM, although it decreased total protein levels (SI and SGLT1 whole cell homogenates). So, 
RA seems to be inhibiting the expression of these two genes but not translocation. 
In case of RA effects on GLUT2, there was no effect on gene expression of GLUT2 (whole 
cell homogenate). However, in HGD fed animals, RA decreased BBM GLUT2 which may be 
the result of inhibition of GLUT2 translocation to the BBM. This effect of RA was not 
apparent in HAD fed animals where GLUT2 expression in BBM was not induced.  
 Our results show that: 
-RA decreases BBM translocation of GLUT2 induced by high luminal glucose 
-RA decreases SGLT1 gene expression rather than translocation to the BBM induced by high 
luminal glucose that is not prevented at 4 days. However at low luminal glucose (4 day 
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HAD), RA shows a inhibition in SGLT1 translocation to the BBM, but not gene expression 
inhibition. 
-RA decreases SI gene expression and seems also to be effective preventing its BBM 
translocation.
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CHAPTER 4 
CONCLUSION 
In conclusion, our study shows that HGD and HAD increase the level of BBM protein of SI 
and SGLT1 whereas only HGD seems to have an effect on increasing the gene expression of 
these protein in total homogenates. In addition, from our data, it is suggested that free luminal 
glucose at low amount (HAD) may responsible to enhance mainly the translocation of SI and 
SGLT1 whereas higher amount of luminal glucose may result in the increase in gene 
expression of these two protein. 
GLUT2, on the other hand, just has the significant increase in translocation to the BBM due to 
the present of free luminal glucose. HGD and HAD did not affect consistently on the gene 
expression of GLUT2. 
Rosmarinic acid has a down regulation effects to GLUT2, SGLT1, and SI. 
The fact that diets (HGD, HAD) and RA affects to SGLT1 and SI in the same pattern, 
suggests that SGLT1 and SI expression is control by similar mechanism. Since we found no 
effect of RA on SGLT1 and SI BBM level at 4 day HGD fed animals , it is suggested that RA 
may interferes to some factors that control the transcription process of these two proteins. One 
of these factors can be “the binding of histone acetyl-transferase GCN5 and acetylation of 
histone H3/H4 on these genes” (Seiya Inoue, 2011). So that, we suggest doing further 
experiments to check whether RA helps decrease the binding of GCN5 and acetylation of 
histone H3/H4 on the transcription process of these two genes.  
 40 
 
 41 
 
BIBLIOGRAPHY  
Aronoff SL, Berkowitz K, Shreiner B & Want L, 2004. Glucose metabolism and regulation: 
beyond insulin and glucagon. Diabetes Spectrum 17, 183-190. 
Avezdo Mariza F. et al., 2008. Evaluation of the antidiabetic efficacy and safety of medicinal 
plants of genus Salvia. Biology department, University of Minho, Portugal. 
Azevedo Marisa F. et al., 2011. Rosmarinic acid, major phenolic constituent of Greek sage 
herbal tea, modulates rat intestinal SGLT1 levels with effects on blood glucose. Mol Nutr 
Food Res 55, 1-11. 
Azevedo Mariza F. et al., 2010. Ursolic acid and luteolin-7-glucoside improve lipid profiles 
and increase liver glycogen content through glycogen synthase kinase-3. Phytother Res 24, 
S220-S224. 
Bouche C et al., 2004. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr 
Rev 25, 807-830. 
Day C, 1998. Traditional plant treatments for diabetes mellitus: pharmaceutical foods. Br J 
Nutr 80, 5-6. 
Drozdowski LA & Thomson AB, 2006b. Intestinal sugar transport. World Gastroenterol 12, 
1657-1670. 
Elfeber K et al., 2004. Localization of the Na+ - D-glucose cotransporter SGLT1 in the blood-
brain barrier. Histochem Cell Biol 121, 201-207. 
F.S D’Amelio, 1999. Botanicals, a phytocosmetic desk reference. CRC press London, 361. 
George L.Kellet et al., 2008. Sugar absorption in the intestine: the role of GLUT2. Annual 
Rev.Nutr.28, 35-54. 
Goda et al., 1994. Dietary carbohydrate and fat independently modulate disaccharidase 
activities in rat jejunum. American Institute of Nutrition. 
Hogan A et al., 1991. Glucose transporter gene expression in early mouse embryos. 
Development 113, 363-372. 
Kazuaki Ohtsubo et al., 2005. Dietary and genetic control of glucose transporter 2 
glycosylation promotes insulin secretion in suppressing diabetes. Cell 123, 1307-1321. 
 42 
 
Kazuhiro Kishi et al., 1999. Sucrase-isomaltase and hexose transporter gene expressions are 
coordinately enhanced by dietary fructose in rat jejunum. American society for nutritional 
sciences. 
Kazuki Mochizuki et al., 2010. Feeding rats a high fat/carbohydrate ratio diet reduce jejunal 
S/I activity and unsialylated galactose on glycosylated chain of S-I complex. Life Sciences 86, 
524-531. 
Maike Petersen et al., 2003. Rosmarinic acid. Phytochemistry 62, 121-125. 
Miller DL, 1971. Rat small intestine: development, composition and effects of perfusion. Am 
J Dig Dis 16, 246-254. 
Oliver J.Mace et al., 2007. Sweet taste receptors in rat small intestine stimulate glucose 
absorption through apical GLUT2. J Physiol 582, 379-392. 
Panayotova-Heiermann M et al., 1997. Five transmembrane helices form the sugar pathway 
the Na+/glucose cotransporter. J Biol Chem 272, 20324-20327. 
Parnham MJ and Kesselring K, 1985. Rosmarinic acid. Drugs of the future 10, 756-757 
Rhoades & Pflanzer, 2003. Human physiology 4th ed. CA, US: Thomson Learning, Inc. 
Brooks/Cole. Chapter 22: The gastrointestinal system. 
Roberson RP & Harmon JS, 2006. Diabetes, glucose, and oxidative stress: A case of double 
jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 41, 177-184. 
Seiya Inoue et al., 2011. Jejunal induction of SI and SGLT1 genes in rats by high-starch/low-
fat diet is associated with histone acetylation and binding of GCN5 on the genes. J Nutr Sci 
Vitaminol 57, 162-169. 
Suzuki T et al., 2001. The apical localization of SGLT1 glucose transporter is determined by 
the short amino acid sequence in its N-terminal domain. Eur J Cell Biol 80, 765-774. 
Toth J. et al., 2003. Rosmarinic acid-an important phenolic active compound of lemon balm 
(Melissa officinalis L.) 
Vuksan V & Sievenpiper JL, 2005. Herbal remedies in the management of diabetes: lessons 
learned from the study of ginseng. Nutr Metab Cardiovasc Dis 15, 149-160. 
Woudstra & Thomson AB, 2002. Nutrient absorption and intestinal adaptation with ageing. 
Best Pract Res Clin Gastroenterol 16, 155-162. 
Wright EM , 2001. Renal Na+/glucose cotransporters. AM J Physiol 280, F10-F18. 
 43 
 
Wright EM et al., 1997. Regulation of Na+/glucose cotransporters. J Intern Med 200, 287-293. 
Wright EM et al., 2002. Molecular basis for glucose-galactose malabsorption. Cell Biomed 
Biophys 36, 115-121 
Wright EM et al., 2003. Intestinal absorption in health and disease – sugars. Best Pract Res 
Clin Gastroenterol 17, 943-956. 
Wright EM et al., 2004. Surprising versatility of Na+-glucose cotransporters: SLC5. 
Physiology (Bethesda) 19, 370-376. 
Wright EM et al., 2007. Active sugar transport in health and disease. J Intern Med 261, 32-43. 
Wright EM, 1998. Glucose galactose malabsorption. AM J Physiol 275, G879-G882. 
Yoshida A et al., 1995. Immunohistochemical localization of Na+-dependent glucose 
transporter in the digestive tract. Histochem J 27, 420-426. 
Zhou L et al., 2003. Human cardiomyocytes express high level of Na+/glucose cotransporter 1 
(SGLT1).  J cell Biochem 90, 339-346. 
 
